Bafna Pharmaceuticals

Bafna Pharmaceuticals

117.11
+5.57
(4.99%)
Market Cap
277.04 Cr
EPS
-15.52
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
114.97
52 Week Low
69.00
PB Ratio
5.21
Debt to Equity
0.70
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Bafna Pharmaceuticals Re-appoints Two Independent Directors and CEO for Five-Year TermsAug 12, 2025
Bafna Pharmaceuticals Limited's Board of Directors approved the re-appointment of Mrs. Ravichandran Chitra and Mr. Palamadai Krishnan Sundaresan as Non-Executive Independent Directors for second terms of five years each, effective November 12, 2025 and September 19, 2025 respectively, subject to shareholder approval. The Board also re-appointed Mr. Bafna Mahaveer Chand as Chief Executive Officer for a further five-year term effective September 10, 2025. Mrs. Chitra brings over three decades of experience in Human Resource Management and related fields, while Mr. Sundaresan is a qualified CMA and CS with over 40 years of multi-industry experience. Mr. Chand, a Chemistry graduate with over four decades in the pharmaceutical industry, has led the company to establish a DSIR-approved R&D centre, secure UK-MHRA accreditation, and win multiple national and international awards for quality and excellence.
positive
Bafna Pharmaceuticals Limited approved its unaudited financial results for the quarter ended June 30, 2025. The company reported revenue from operations of ₹3,462.40 lakhs compared to ₹3,328.63 lakhs in the same quarter last year. Net profit for the quarter was ₹338.89 lakhs versus a loss of ₹72.36 lakhs in the corresponding previous quarter. The company scheduled its 30th Annual General Meeting for September 19, 2025, to be held through video conferencing. Book closure dates are set from September 13-19, 2025, with the cut-off date for voting eligibility being September 12, 2025. The board also reconstituted the Nomination & Remuneration Committee with Mr. Navin Kumar as Chairman, Mrs. Ravichandran Chitra and Mrs. Akila Chintalapati Raju as members. The company achieved the prescribed Minimum Public Shareholding as of April 2, 2025, and completed the sale of assets from its Madhavaram manufacturing unit during the quarter.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,616.60
#1 3,87,876.49
33.67
#1 54,729.00
9.71
#1 10,980
-19.84
49.00
6,026.50
1,59,984.64
69.22
9,712.00
18.67
2,191
26.74
39.47
1,574.60
1,27,181.67
23.38
28,409.50
7.12
5,291
9.88
52.08
3,566.20
1,20,696.41
60.00
11,539.40
6.99
1,911
19.91
48.74
1,316.70
1,09,887.98
#1 19.15
33,741.20
16.73
5,725
1.26
60.35
2,579.60
1,06,467.51
56.70
12,744.20
#1 20.90
2,007
-18.14
58.41
1,044.75
1,05,126.30
22.52
23,511.00
18.55
4,615
2.60
68.18
2,043.40
93,321.15
24.55
22,909.50
13.74
3,306
#1 51.64
59.44
30,980.00
65,830.34
45.32
6,684.70
9.64
1,414
11.55
39.39
5,448.00
65,139.01
28.38
13,458.30
3.70
2,216
21.39
63.73
Forecast
Actual
Growth Rate
Revenue Growth
-2.95 %
Net Income Growth
-90.21 %
Cash Flow Change
-1,816.76 %
ROE
-96.42 %
ROCE
-90.07 %
EBITDA Margin (Avg.)
-112.00 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Jun 2019
Sept 2019
Revenue
12
9
7
12
Expenses
14
9
10
12
EBITDA
-2
0
-3
0
Operating Profit %
-15 %
2 %
-42 %
-3 %
Depreciation
1
1
1
1
Interest
1
1
0
0
Profit Before Tax
-4
-1
-4
-1
Tax
0
0
-2
0
Net Profit
-4
-1
-2
-1
EPS in ₹
0.00
-0.80
-0.90
-0.25

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
Total Assets
200
193
178
138
120
71
Fixed Assets
55
53
49
45
37
35
Current Assets
127
123
77
49
49
36
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
17
0
0
0
Other Assets
145
140
113
94
82
36
Total Liabilities
200
193
178
138
120
71
Current Liabilities
111
95
82
60
71
17
Non Current Liabilities
16
40
55
41
30
3
Total Equity
73
58
42
37
19
51
Reserve & Surplus
53
39
20
14
-5
-7
Share Capital
19
19
19
24
24
2

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
Net Cash Flow
0
-0
-0
0
-0
6
Investing Activities
60
-0
-5
38
15
33
Operating Activities
11
1
-1
-7
-2
-34
Financing Activities
-71
-1
6
-31
-14
7

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
91.74 %
90.39 %
90.40 %
90.42 %
90.42 %
90.12 %
90.00 %
90.02 %
90.00 %
90.00 %
88.74 %
88.43 %
88.30 %
88.30 %
88.30 %
88.30 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.53 %
9.34 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.31 %
6.23 %
6.26 %
6.10 %
5.24 %
5.50 %
5.62 %
5.61 %
5.64 %
5.64 %
6.87 %
7.66 %
7.48 %
7.37 %
7.69 %
7.66 %
11.06 %
11.62 %
Others
1.95 %
3.37 %
3.34 %
3.49 %
4.33 %
4.38 %
4.38 %
4.37 %
4.37 %
4.36 %
4.39 %
3.91 %
4.23 %
4.34 %
4.01 %
4.04 %
5.40 %
4.04 %
No of Share Holders
8,603
8,330
8,068
7,910
7,326
7,223
7,275
7,199
7,120
6,992
7,354
7,367
7,539
7,391
7,295
7,214
7,142
7,283

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 91.46 111.54
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 82.30 80.11
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 80.13 81.90
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 77.43 78.02
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 76.88 73.00
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 83.14 91.46

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2025
Notice Of 30Th Annual General Meeting Of The Company For The F.Y 2024-2025Aug 26, 2025
Reg. 34 (1) Annual Report.Aug 26, 2025
Book Closure For 30Th Annual General Meeting (AGM)Aug 21, 2025
Shareholder Meeting - 30Th AGM On September 19 2025Aug 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On 12/08/2025Aug 12, 2025
Board Meeting Intimation for Meeting Scheduled On August 12 2025Aug 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 05, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Jun 30, 2025
Closure of Trading WindowJun 26, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Re-Constitution Of CommitteesJun 24, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 24, 2025
Announcement under Regulation 30 (LODR)-RetirementJun 24, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 23, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Audited Financial Results For The Quarter & Year Ended March 31 2025May 26, 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On 26/05/2025May 26, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Re-Constitution Of Nomination & Remuneration Committee.May 20, 2025
Board Meeting Intimation for Board Meeting Scheduled On May 26 2025May 19, 2025
Announcement Under Reg 30 Of SEBI (LODR) Regulations 2015 - AwardApr 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 01, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 01, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 01, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 01, 2025
Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations 2015Mar 31, 2025
Notice of Offer for Sale of Shares by Promoter & Flooor PriceMar 26, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Integrated Filing (Financial)Feb 06, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended 31/12/2024Feb 06, 2025
Board Meeting Outcome for Board Meeting Held On 06/02/2025Feb 06, 2025
Board Meeting Intimation for Board Meeting Scheduled On February 06 2025Jan 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Unaudited Financial Results For The Quarter Ended 30.09.2024Nov 11, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 11/11/2024Nov 11, 2024
Update on board meetingNov 04, 2024
Board Meeting Intimation for Board Meeting Scheduled On November 11, 2024Nov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Closure of Trading WindowSep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 26, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 25, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2024

Technical Indicators

RSI(14)
Neutral
65.66
ATR(14)
Less Volatile
5.83
STOCH(9,6)
Neutral
59.99
STOCH RSI(14)
Neutral
76.05
MACD(12,26)
Bullish
0.15
ADX(14)
Weak Trend
16.88
UO(9)
Bearish
53.58
ROC(12)
Uptrend And Accelerating
16.62
WillR(14)
Overbought
0.00